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Objective: To estimate risks of maternal and neonatal complications in pregnancies with 
macrosomia. 
Method: This was a retrospective cohort study undertaken at a large maternity unit in United 
Kingdom between January 2009-December 2016. We compared the incidence of complications 
in pregnancies with macrosomia, defined by birthweight (BW)>4,000 g and severe macrosomia 
with BW>4,500 g, to those in pregnancies with normal BW 2,500-4,000 g. Regression analysis 
was undertaken to determine odds ratios (OR) [95% confidence interval (CI)] for pregnancy 
complications in macrosomic compared to normal BW group. 
Results: The study population of 35,548 pregnancies included 4,522 (12.7%) with macrosomia, 
643 (1.8%) with severe macrosomia and 31,026 (87.3%) with normal BW. In macrosomia group, 
adjusted OR was 3.07 (95%CI:1.64,2.01) for cesarean section for failure to progress, 2.40 
(95%CI:1.95,2.96) for post-partum haemorrhage, 2.29 (95%CI:1.86,2.82) for sphincter injury, 
10.37 (95%CI:8.57,12.55) for shoulder dystocia, 28.48 (95%CI:8.94,90.67) for brachial plexus 
injury, 32.33 (95%CI:3.76,278.15) for birth fractures and 4.40 (95%CI:2.20,8.82) for hypoxic-
ischemic encephalopathy. The respective values for severe macrosomia were 4.32 
(95%CI:3.05,6.13), 2.93 (95%CI:1.93,4.44), 3.12 (95%CI:1.92,5.08), 28.74 (95%CI:20.75,39.79), 
73.92 (95%CI:15.05,363.16), 87.17 (95%CI:7.72,984.96) and 13.77 (95%CI: 5.16,36.75). 
Conclusion: Macrosomia is associated with serious adverse perinatal outcomes. This study 








Fetal macrosomia is commonly defined as a neonatal birth weight (BW) of more than 4,000 g1-3. 
This cut-off corresponds to the 90th percentile at 40 weeks’ gestation and therefore the 
prevalence of macrosomia is approximately 10% 3,4. Fetal macrosomia is associated with 
maternal complications, such as emergency caesarean section (CS), post-partum hemorrhage 
(PPH), perineal trauma and neonatal complications, including shoulder dystocia, brachial plexus 
injury (OBPI), fracture of the humerus or clavicle and birth asphyxia 5-7. However, there is 
considerable variation in the reported literature with regard to study design, sample size, type of 
complications reported and the lack of adjustment for confounding factors affecting the outcome 
measures, which introduces a significant bias in estimation of risks of these complications 5,6,8-14.  
 
The objective of our study was to first, estimate absolute risks (AR) of maternal and neonatal 
complications in pregnancies with macrosomia; second, determine odds ratios (OR) for these 
complications, after adjusting for maternal and pregnancy characteristics, and third, determine 
AR and relative risks (RR) for macrosomic BWs for each complication as well as composite 
maternal and neonatal outcomes. 
 
 
Materials and Methods 
 
Study population 
This was a retrospective cohort study undertaken in a large obstetric and neonatal unit at 
Medway NHS Foundation Trust, Gillingham in the United Kingdom during the period of 1st 
January 2009 to 31st December 2016. In our hospital, all women attend the Fetal Medicine Unit 
at 11-13 weeks’ gestation for an ultrasound examination. In this visit we record maternal 
demographic characteristics and medical history on an electronic database (Viewpoint version 
5.6; General Electric Company). Details of intrapartum care and information regarding neonatal 
care for those neonates admitted to the Neonatal Intensive Care Unit (NICU) are recorded in 
separate electronic databases (Euroking Maternity Software, Wellbeing software, Mansfield, 
United Kingdom; BadgerNet Neonatal Electronic Patient Record; Edinburgh, United Kingdom). A 
common database was constructed which contained information about maternal demographics, 
obstetric and medical history, antenatal, intrapartum and neonatal details by combining 
electronic searches of each of these databases. This study was a retrospective analysis of 
routinely collected pregnancy outcomes as part of routine clinical care and did not qualify for 
ethical approval. 
 
Inclusion and exclusion criteria 
The inclusion criteria were singleton pregnancies which booked and delivered at our hospital 
and birth of phenotypically normal neonates at ≥ 24 weeks’ gestation. We excluded multiple 
pregnancies, miscarriages, stillbirths, terminations of pregnancy, those with major fetal defects 
and those that were lost to follow-up. 
 
Patients meeting the inclusion criteria were subdivided according to BW into macrosomia (BW > 
4000 g), normal (BW 2,500 - 4,000 g) and small (BW < 2,500 g). In the macrosomia group, a 
subgroup of severe macrosomia was identified (BW > 4,500 g). The small BW group was 
excluded from further analysis to avoid confounding effects on the rate of maternal and neonatal 
complications due to prematurity and low BW. Comparisons were made between the 





Maternal complications: The maternal complications which were examined were rates of 
prolonged 1st and 2nd stage of labor, instrumental vaginal delivery, failed instrumental delivery 
requiring CS, emergency CS for any indication, CS for failure to progress (FTP) in labor, PPH 
and obstetric anal sphincter injury (OASIS). Prolonged 1st stage was defined as a duration of 
labor > 18 hours in nulliparous women and > 12 hours in multiparous women 15. Prolonged 2nd 
stage was defined as duration > 2 hours in nulliparous women and > 1 hour in multiparous 
women 15. Vaginal deliveries requiring either vacuum extraction or forceps were classified as 
instrumental births and those that required a CS following an unsuccessful application of either 
instrument were classified as failed instrumental deliveries 16. Lucas classification was used to 
classify CS as an elective or emergency 17. PPH was defined as an estimated blood loss (EBL) 
> 500 mL in the third stage of labor and was classified as minor (500-1000 mL), moderate 
(1001-2000 mL) or severe (> 2000 mL) 18. OASIS encompassed third and fourth degree vaginal 
tears which involved a perineal injury to the anal sphincter complex and anorectal mucosa 19.  
 
Neonatal complications: Shoulder dystocia was defined as a vaginal delivery that required 
additional obstetric manoeuvres to deliver the fetus after delivery of the head and failure of 
gentle traction 20.  We divided shoulder dystocia into two groups: the first group included any 
shoulder dystocia that required any manoeuvres and the second group included severe dystocia 
defined as need for internal obstetric manoeuvres, such as Wood’s corkscrew, Rubin’s or 
delivery of posterior arm 21. OBPI resulting from a traction injury to the nerves during delivery 
was defined in the NICU following clinical examination by a senior neonatologist based on 
evidence of upper limb weakness or paralysis 22. Birth fracture to the clavicle or humerus was 
diagnosed by an X-ray examination. Hypoxic-ischemic encephalopathy (HIE) was diagnosed 
when there was disturbed neurologic function with evidence of perinatal hypoxia reflected in 
either a 5-minute APGAR score < 5 or umbilical artery cord pH < 7.0 or base deficit > 12 mmol/L, 
supported by neuroimaging evidence of acute brain injury 23. Hypoglycaemia was defined by 
neonatal serum glucose level < 2.6 mmol/L  24. 
 
Composite of maternal and neonatal complications: We combined emergency CS for FTP, 
severe PPH and OASIS into one composite maternal group. Similarly, shoulder dystocia, birth 
fractures/OBPI and HIE were combined into one composite neonatal group. These 
complications are likely to occur together and therefore, an estimate of risk of any one of these 
adverse outcomes as a composite measure will potentially reduce overestimation of such risks. 
 
Statistical analysis 
Comparison of the maternal and pregnancy characteristics in the outcome groups was by the χ2-
square test and Fisher’s exact test for categorical variables and Mann-Whitney U-test for 
continuous variables, respectively. Significance was assumed at 5% and Bonferroni correction 
was used to adjust for multiple comparisons where necessary.  
 
Data for maternal and neonatal complications were entered into contingency tables and absolute 
risks (AR) for maternal and neonatal complications were estimated by determining the 
prevalence of these complications in macrosomia and severe macrosomia groups divided by the 
prevalence in the normal BW group. Logistic regression analysis was carried out in the case of 
each maternal and neonatal complication to estimate unadjusted univariate OR with 95% 
confidence intervals (CI). Multivariate OR (95% CI) were derived from logistic regression 
analysis with backward stepwise elimination by introducing maternal demographic factors, 
pregnancy and labor characteristics and macrosomia or severe macrosomia as a binary variable 
into the regression analysis. Prior to the regression analysis, the continuous variables, such as 
age, weight and height were centred by subtracting the arithmetic mean from each value to 
avoid effects of multicollinearity. The final model was a combination of variables that provided a 
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significant contribution to the prediction of the maternal or neonatal complications in the 
regression analysis. Estimates of AR were derived for severe maternal and neonatal 
complications and their respective composite adverse outcomes for BW from 4,000 to 6,000 g. 
We then derived RR for each BW category by dividing the AR in macrosomia by the AR in the 
normal BW group. Forest plots were constructed to express the OR (95% CI) for the 
macrosomia and severe macrosomia groups for maternal and neonatal complications. BW was 
regressed against the severe maternal and neonatal complications to graphically demonstrate 
the increase in risk of these complications with increasing BW.  
 
The statistical package SPSS 24.0 (IBM SPSS Statistics for Windows, Version 24.0, Armonk, 
NY: IBM Corp; 2016) and MedCalc Statistical Software version 18.5 (MedCalc Software, Ostend, 






During the study period, 37,653 singleton pregnancies fulfilled the entry criteria, including 31,026 
(82.4%) with normal BW, 4,522 (12.0%) with macrosomia and 2,105 (6.4%) with low BW. The 
macrosomia group included 643 (14.2%) with severe macrosomia. The group with small babies 
was not considered for further analysis. 
 
The maternal and pregnancy characteristics in the study groups are compared in Table 1. In the 
macrosomic group, compared to the normal group, there was a higher median maternal age, 
weight and height, lower incidence of women of South Asian origin and cigarette smokers and 
higher incidence of gestational diabetes mellitus (GDM). With regard to pregnancy 
characteristics, in the macrosomic group, compared to the normal group, there was a higher 
median gestational age at delivery, EBL and a higher proportion of women undergoing induction 
of labor (IOL).  
 
Maternal complications  
In the macrosomia group, there was a significantly higher prevalence of all maternal 
complications (Table 2, Figure 1), with a 3-fold increased risk of CS for FTP and 2.5-fold 
increased risk of severe PPH and OASIS (Table 3, Figure 1). In the severe macrosomia group, 
there was a significantly increased risk for all adverse outcomes except for failed instrumental 
delivery, with a 4-fold increased risk of CS for FTP and a 3-fold increased risk for severe PPH 
and OASIS (Table 3, Figure 1). The risks of adverse maternal outcomes increased exponentially 
with increasing BW (Table 4, Figure 3). 
 
Neonatal complications in the study groups 
In the macrosomia group, there was a significantly higher prevalence of all neonatal 
complications (Table 2, Figure 2), with a 10-fold increased risk of shoulder dystocia, a 20-fold 
increased risk of severe shoulder dystocia, a 30-fold increased risk of BPI and birth fractures 
and a 2-fold increased risk of HIE (Table 3, Figure 2). In the severe macrosomia group, there 
was a significantly higher prevalence of all adverse outcomes, with a 70 to 80-fold increased risk 
of severe shoulder dystocia, OBPI and birth fractures and a 4-fold increased risk of HIE (Table 3; 
Figure 2). The risk of adverse neonatal outcomes increased exponentially with increasing BW 
after 4,000 g (Table 4, Figure 4). 
 
Risk of composite adverse outcomes 
6 
 
The background risk of a composite maternal morbidity in the normal BW group was 6.0% and 
this increased from 10.4% at BW of 4,000 g, to 15.8% at BW of 4,500 g and 23.4% at BW of 
5,000 g (Table 4). The background risk of composite neonatal morbidity in the normal BW group 
was 1.1% and this increased from 3.9% at BW of 4,000 g, to 12.6% at BW of 4,500 g and 33.6% 





Principal findings of the study 
The results of our study demonstrate that pregnancies with macrosomia are associated with a 
significantly increased risk for serious maternal and neonatal adverse outcomes including CS for 
FTP, severe PPH, OASIS, shoulder dystocia, OBPI, fractures and HIE. This increased risk of 
adverse outcomes is more substantial for the neonate than for the mother and the risk of 
complications is relatively low until 4,000 g increasing exponentially thereafter. The composite 
maternal adverse outcome increased from approximately, 2-fold at 4,000 g to 3-fold at 4,500 g, 
whereas the composite neonatal adverse outcome increased from 3-fold at 4,000 g to 10-fold at 
4,500 g.  
 
Strengths and limitations 
The strengths of the study are first, examination of a large cohort of consecutively screened and 
delivered pregnancies in a large obstetric and neonatal unit; second, accurate ascertainment of 
maternal demographic and pregnancy characteristics to ensure there are no missing data; third, 
accurate ascertainment of maternal and neonatal adverse outcomes; fourth, estimation of risks 
for adverse outcomes after adjustment for maternal, pregnancy and labour characteristics; fifth, 
reporting of absolute and relative risks for adverse outcomes for BW ranging from 4,000 to 6,000 
g to aid in antenatal counselling for provision of standardized information. 
 
This is a single centre study and to a degree, the reported incidence of maternal and neonatal 
complications would be affected by the characteristics of the population and the protocols for 
antenatal and intrapartum care. However, there is no reason to believe that the absolute and 
relative risks of complications in the macrosomia group compared to those with a normal BW 
would vary substantially in different populations. 
 
Comparison with other studies 
Several studies have reported on the association of fetal macrosomia with adverse pregnancy 
outcomes but there is considerable variation in these studies with regard to design, sample size 
and types of adverse outcomes reported 5-14. Some studies are case-control, some cohort 
studies and others population studies extracted from electronic databases without checking 
veracity of the reported outcome measures 5-7, 14. The sample size in studies ranges from as 
small as 100 in some to more than 100,000 in others 6,11. A significant potential bias is related to 
how the maternal and neonatal outcomes measures are obtained, which is reflected in the huge 
variation, not just the prevalence of these complications but also in the prevalence of 
macrosomia, which ranges from 0.9% in one study to 29.3% in another 14,25. The studies largely 
report ARs or unadjusted OR based on prevalence of complications without adjusting for other 
factors that contribute to such complications with only a couple reporting adjusted OR 6,12. 
Although, there is an appreciation of increased adverse outcomes for macrosomia, the variation 
in studies and biases resulting from such heterogeneity make it difficult to determine accurate 
risks of pregnancy complications from the reported literature. In our study, we examined the 
maternal and neonatal risks in a large unselected screened population in a cohort study with 
accurate determination of maternal and pregnancy characteristics, ascertaining the outcome 
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measures of complications accurately and reporting not just unadjusted risks but also 
multivariate OR by adjusting for other factors using regression analysis. 
 
Conclusion 
Our study confirms the association that pregnancies with macrosomia are associated with 
serious maternal and neonatal adverse outcomes. This study provides estimates of these risks 
that can be used for decisions on pregnancy management.  
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Table 1. Maternal and pregnancy characteristics in pregnancies with fetal macrosomia 
compared with those delivering non-macrosomic fetuses 
IQR = interquartile range;   
Adjusted Bonferroni significance level p=0.025; ** p<0.0001; *p<0.01. 
Maternal and pregnancy characteristics 
Normal BW 
BW 2500-4000 g 
(n=31,026) 
Macrosomia 
BW >4000 g 
(n=4,522) 
BW >4500 g 
(n=643) 
Maternal age in years, median (IQR) 28.6 (24.3-32.7) 29.4 (25.5-33.2)** 30.0 (26.1-34.0)** 
Maternal weight in kg, median (IQR) 66.0 (58.0-78.0) 73.1 (63.9-86.0)** 77.0 (66.0-90.0)** 
Maternal height in mt, median (IQR) 1.64 (1.60-1.68) 1.67 (1.62-1.70)** 1.68 (1.63-1.72)** 
Racial origin  
   Caucasian (Reference), n (%) 28,036 (90.4) 4,253 (94.1) 600 (93.3) 
   Afro-Caribbean, n (%) 999 (3.2) 122 (2.7) 21 (3.3) 
   South Asian, n (%) 1,475 (4.8) 94 (2.1)** 13 (2.0)* 
   East Asian, n (%) 132 (0.4) 15 (0.3) 2 (0.3) 
   Mixed, n (%) 384 (1.2) 38 (0.8)* 7 (1.1) 
Conception  
   Spontaneous (Reference), n (%) 30,796 (99.3) 4,485 (99.2) 638 (99.2) 
   Assisted conception, n (%) 230 (0.7) 37 (0.8) 5 (0.8) 
Cigarette smoking, n (%) 5,736 (18.5) 462 (10.2)** 57 (8.9)** 
History of medical disorders  
    Chronic hypertension, n (%) 265 (0.9) 25 (0.6) 7 (1.1) 
    Pre-existing diabetes mellitus, n (%) 197 (0.6) 30 (0.7) 2 (0.3) 
    Gestational diabetes mellitus, n (%) 839 (2.7) 136 (3.0) 32 (5.0)** 
    Asthma, n (%) 1,826 (5.9) 243 (5.4) 37 (5.8) 
    Epilepsy, n (%) 199 (0.6) 22 (0.5) 1 (0.2) 
Parity  
   Nulliparous (Reference), n (%) 15,948 (51.4) 1,999 (44.2) 259 (40.3) 
   Parous without macrosomia, n (%) 13,419 (43.3) 1621 (35.8)** 179 (27.8) 
   Parous with macrosomia, n (%) 1,659 (5.3) 902 (19.9)** 205 (31.9) 
Gestation at delivery, median (IQR) 39.6 (39.6-40.5) 40.6 (40.0-41.3)** 41.0 (40.2-41.4)** 
Onset of labour  
    Spontaneous (Reference), n (%) 20,728 (66.8) 2,751 (60.8) 343 (53.4) 
    No labour – elective delivery, n (%) 3,192 (10.3) 412 (9.1) 71 (11.0) 
    Induction of labour, n (%) 7,106 (22.9) 1,359 (30.1)** 229 (35.6)** 
Mode of delivery  
    Spontaneous vaginal (Reference), n (%) 20,832 (67.1) 2,781 (61.5)** 356 (55.4) 
    Instrumental vaginal delivery, n (%) 2,795 (9.0) 452 (10.0) 54 (8.4) 
    Elective caesarean section, n (%) 3,192 (10.3) 412 (9.1) 71 (11.0) 
    Emergency caesarean section, n (%) 4,207 (13.6) 877 (19.4)** 162 (25.2) 
Estimated blood loss, median (IQR) 300 (250-500) 400 (300-600)** 450 (300-700)** 
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Table 2. Absolute risk of maternal and neonatal complications in pregnancies with macrosomia 
compared to those with normal birth weight (BW) 
 
CS=caesarean section; FTP=failure to progress; OBPI= Obstetric brachial plexus injury; HIE= 
Hypoxic ischaemic encephalopathy 
Adjusted Bonferroni significance level p=0.025; ** p<0.0001; *p<0.01 
Absolute risks calculated as a proportion of vaginal deliveries only1, all instrumental deliveries 
attempted2, all deliveries excluding elective CS3, all deliveries excluding elective CS and those for 
fetal distress4  
Complications 
Normal BW 
BW 2500 – 4000 g 
(n=31,026) 
Macrosomia 
BW >4000 g 
(n=4,522) 
BW >4500 g 
(n=643) 
Maternal    
Prolonged 1st stage, n/N (%) 1,895/26,200 (7.2) 408/3,882 (10.5)** 63/513 (12.3)** 
Prolonged 2nd stage, n/N (%) 1,533/24,838 (6.2) 306/3,694 (8.3)** 43/486 (8.8)* 
Instrumental deliveries, n/N (%) 1 2,795/23,627 (11.8) 452/3,233 (14.0)** 54/410 (13.2) 
Failed instrumental deliveries, n/N (%) 2 103/2,898 (3.5) 31/483 (6.4)* 3/57 (5.3) 
Emergency CS – All, n/N (%) 3 4,207/27,834 (15.1) 877/4,110 (21.3)** 162/572 (28.3)** 
Emergency CS – FTP, n/N (%) 4 832/24,459 (3.4) 295/3,528 (8.4)** 52/462 (11.3)** 
Post-partum hemorrhage – All, n/N (%) 2,098/31,026 (6.7) 587/4,522 (13.0)** 99/643 (15.4)** 
Post-partum hemorrhage – Severe, n/N (%) 344/31,026 (1.1) 137/4,522 (3.0)** 26/643 (4.0)** 
Obstetric anal sphincter injury, n/N (%) 1 478/23,627 (2.0) 121/3,233 (3.7)** 19/410 (4.6)** 
Neonatal    
Shoulder dystocia – All, n/N (%) 1 247/23,627 (1.0) 256/3,233 (7.9)** 70/410 (17.1)** 
Shoulder dystocia - Severe, n/N (%) 1 26/23,627 (0.1) 60/3,233 (1.9)** 24/410 (5.9)** 
OBPI, n/N (%) 1 4/23,627 (0.02) 12/3,233 (0.4)** 3/410 (0.7)** 
Birth Fractures, n/N (%) 1 1/23,627 (0.004) 5/3,233 (0.2)** 2/410 (0.5)** 
HIE, n/N (%) 1 21/23,627 (0.1) 13/3,233 (0.4)** 5/410 (1.2)** 
Hypoglycemia, n/N (%) 413/31,026 (1.2) 77/4,522 (1.7)* 20/643 (3.1)** 
12 
 
Table 3. Risk of maternal and neonatal complications in macrosomia pregnancies expressed as univariate and multivariate odds 
ratios (OR) with 95% confidence interval (CI) 
  
 
CS=caesarean section; FTP=failure to progress; PPH= Post-partum haemorrhage; OASIS=Obstetric anal sphincter injury; OBPI= 
Obstetric brachial plexus injury; HIE= Hypoxic ischaemic encephalopathy; CI=confidence interval.   
Complications 
Macrosomia (BW >4,000 g) Severe macrosomia (BW >4,500 g) 
Univariate  
OR (95% CI) 
Multivariate 
OR (95% CI) 
Univariate  
OR (95% CI) 
Multivariate 
OR (95% CI) 
Maternal  
Prolonged 1st stage 1.51 (1.35-1.69) 1.55 (1.37-1.76) 1.80 (1.37-2.35) 1.75 (1.29-2.37) 
Prolonged 2nd stage 1.37 (1.21-1.56) 1.28 (1.12-1.48) 1.48 (1.07-2.03) 1.30 (0.92-1.83) 
Instrumental deliveries 1.21 (1.09-1.35) 1.51 (1.33-1.71) 1.13 (0.85-1.51) 1.51 (1.09-2.10) 
Failed instrumental deliveries 1.86 (1.23-2.82) 1.87 (1.24-2.85) 1.51 (0.46-4.90) - 
Emergency CS – All  1.52 (1.40-1.65) 1.54 (1.40-1.68) 2.22 (1.85-2.67) 2.12 (1.72-2.60) 
Emergency CS – FTP 2.59 (2.26-2.97) 3.07 (2.62-3.59) 3.60 (2.77-4.84) 4.32 (3.05-6.13) 
PPH – All 2.06 (1.87-2.27) 1.82 (1.64-2.01) 2.51 (2.02-3.12) 1.99 (1.59-2.50) 
PPH – Severe 2.79 (2.28-3.41) 2.40 (1.95-2.96) 3.76 (2.50-5.64) 2.93 (1.93-4.44) 
OASIS 1.88 (1.54-2.31) 2.29 (1.86-2.82) 2.35 (1.47-3.76) 3.12 (1.92-5.08) 
Neonatal  
Shoulder dystocia – All 8.14 (6.81-9.73) 10.37 (8.57-12.55) 19.49 (14.64-25.95) 28.74 (20.75-39.79) 
Shoulder dystocia - Severe 17.17 (10.82-27.24) 20.27 (12.62-32.56) 56.44 (32.12-99.19) 75.64 (41.28-138.62) 
OBPI 22.00 (7.09-68.26) 28.48 (8.94-90.67) 45.53 (9.71-195.12) 73.92 (15.05-363.16) 
Birth Fractures, 36.56 (4.27-313.33) 32.33 (3.76-278.15) 115.81 (10.48-1279.77) 87.17 (7.72-984.96) 
HIE 4.54 (2.27-9.07) 4.40 (2.20-8.82) 13.88 (5.21-36.99) 13.77 (5.16-36.75) 
Hypoglycemia 1.28 (1.01-1.64) 2.04 (1.54-2.69) 2.38 (1.51-3.75) 4.17 (2.50-6.94) 
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Table 4. Estimates of increased risk for maternal and neonatal complications in pregnancies with fetal macrosomia compared to 
those without macrosomia* expressed as absolute risk (percentages) and relative risks (RR) 
 
Em CS- FTP = Emergency caesarean section for failure to progress; PPH = post-partum haemorrhage; OASIS = obstetric anal 
sphincter injury; SD = Shoulder dystocia; BPI = brachial plexus injury; HIE = hypoxic ischaemic encephalopathy 
* Background risk of complications in neonates with birthweight between 2,500 and 4,000g  
BW (g) 
Maternal complications, [%, (RR)] Neonatal complications, [%, (RR)] 
CS-FTP PPH-severe OASIS Composite SD BPI HIE Composite 
Background* 3.4 (1.0) 1.1 (1.0) 2.0 (1.0) 6.0 (1.0) 1.0 (1.0) 0.01 (1.0) 0.1 (1.0) 1.1 (1.0) 
4000 6.3 (1.8) 2.1 (1.9) 3.2 (1.6) 10.4 (1.7) 3.7 (3.7) 0.1 (7.7) 0.2 (2.2) 3.9 (3.6) 
4100 6.9 (2.0) 2.3 (2.1) 3.4 (1.7) 11.3 (1.9) 4.8 (4.8) 0.1 (10.0) 0.2 (2.4) 5.0 (4.5) 
4200 7.7 (2.3) 2.5 (2.3) 3.7 (1.9) 12.3 (2.1) 6.1 (6.1) 0.1 (12.9) 0.3 (2.6) 6.3 (5.8) 
4300 8.5 (2.5) 2.7 (2.5) 4.0 (2.0) 13.4 (2.2) 7.8 (7.8) 0.2 (16.7) 0.3 (28.0) 8.0 (7.3) 
4400 9.4 (2.8) 3.0 (2.7) 4.3 (2.2) 14.6 (2.4) 9.9 (9.9) 0.2 (21.7) 0.3 (3.0) 10.1 (9.1) 
4500 10.3 (3.0) 3.3 (3.0) 4.7 (2.3) 15.8 (2.6) 12.4 (12.4) 0.3 (28.1) 0.3 (3.3) 12.6 (11.4) 
4600 11.4 (3.4) 3.6 (3.3) 5.0 (2.5) 17.2 (2.9) 15.6 (15.6) 0.4 (36.5) 0.4 (3.6) 15.6 (14.2) 
4700 12.6 (3.7) 4.0 (3.6) 5.4 (2.7) 18.6 (3.1) 19.3 (19.3) 0.5 (47.2) 0.4 (3.9) 19.2 (17.5) 
4800 13.8 (4.1) 4.4 (3.4) 5.8 (2.9) 20.1 (3.4) 23.7 (23.7) 0.6 (61.2) 0.4 (4.2) 23.4 (21.3) 
4900 15.2 (4.5) 4.8 (4.4) 6.3 (3.1) 21.7 (3.6) 28.8 (28.8) 0.8 (79.2) 0.5 (4.6) 28.3 (25.7) 
5000 16.7 (4.9) 5.3 (4.8) 6.8 (3.4) 23.4 (3.9) 34.4 (34.4) 1.0 (102.5) 0.5 (5.0) 33.6 (30.6) 
5100 18.2 (5.4) 5.8 (5.3) 7.3 (3.6) 25.2 (4.2) 40.5 (40.5) 1.3 (132.6) 0.5 (5.4) 39.5 (35.9) 
5200 19.9 (5.9) 6.4 (5.8) 7.8 (3.9) 27.1 (4.5) 47.0 (47.0) 1.7 (171.3) 0.6 (5.9) 45.6 (41.5) 
5300 21.7 (6.4) 7.0 (6.4) 7.4 (4.2) 29.0 (4.8) 53.5 (53.5) 2.2 (221.1) 0.6 (6.4) 51.9 (47.2) 
5400 23.7 (7.0) 7.7 (7.0) 9.1 (4.5) 31.1 (5.2) 59.9 (59.9) 2.9 (285.0) 0.7 (6.9) 58.2 (52.9) 
5500 25.7 (7.6) 8.4 (7.6) 9.7 (4.9) 33.2 (5.5) 66.0 (66.0) 3.7 (366.5) 0.8 (7.5) 64.1 (58.3) 
5600 27.9 (8.2) 9.2 (8.3) 10.4 (5.2) 35.4 (5.9) 71.6 (71.6) 4.7 (470.4) 0.8 (8.2) 69.7 (63.4) 
5700 30.1 (8.9) 10.0 (9.1) 11.2 (5.6) 37.6 (6.3) 76.6 (76.6) 6.0 (601.7) 0.9 (8.8) 74.8 (68.0) 
5800 32.5 (9.6) 11.0 (10.0) 12.0 (6.0) 39.9 (6.7) 81.0 (81.0) 7.7 (766.9) 1.0 (9.6) 79.2 (72.0) 
5900 34.9 (10.3) 12.0 (10.9) 12.9 (6.4) 42.3 (7.1) 84.7 (84.7) 9.7 (972.6) 1.0 (10.4) 83.1 (75.5) 





Figure 1. Forrest plot of odds ratios (OR) with 95% confidence intervals (CI) for maternal 
complications in pregnancies with macrosomia (grey diamonds) and severe macrosomia (black 
diamonds) (CS: cesarean section; FTP: Failure to progress; PPH: post-partum hemorrhage; 
OASIS: obstetric anal sphincter injuries) 
 
Figure 2. Forrest plot of odds ratios (OR) with 95% confidence intervals (CI) for maternal 
complications in pregnancies with macrosomia (grey diamonds) and severe macrosomia (black 
diamonds) (HIE: hypoxic ischaemic encephalopathy) 
 
Figure 3. Risk of maternal complications of macrosomia plotted against birth weight. (Cesarean 
section for failure to progress – [     ], obstetric anal sphincter injury – [     ] and severe post-
partum hemorrhage – [····]). 
 
Figure 4. Risk of neonatal complications of macrosomia plotted against birth weight. (Shoulder 
dystocia – [     ], Obstetric brachial plexus injury – [     ] and birth fractures – [····]). 
